Abstract
The majority of tumours in patients with hereditary non-polyposis colon cancer (HNPCC) occur in large intestine and endometrium; also, other tissues are at increased risk. We studied expression of hMLH1 and hMSH2 proteins in 148 normal samples of various tissues from non-HNPCC patients and in 14 normal colon tissues from HNPCC patients. Immunohistochemical technique was used. Intensity of nuclear staining, percentage of stained cells and H-scores were calculated. Tissues were divided into groups. Groups A, B and C included tissues with increased risk of cancer in HNPCC A) stomach, small and large bowel; (B) endometrium; (C) ovary, ureter, urinary bladder, kidney and liver. Group D tissues were without increased risk. Expression of the proteins was significantly higher in groups A, B and C compared with group D (P<0.0001, P=0.0004 for hMSH2 in C versus D). The expression was highest in testis. In colons of HNPCC patients, expression of the mutated gene product was significantly lower than in non-HNPCC patients. In conclusion, hMLH1/hMSH2 protein expression is constitutively higher in certain cell types of certain tissues, including the majority of tissues that are at increased risk of cancer in HNPCC. However, association of strong hMLH1/hMSH2 expression with cancer risk is not strictly valid.
Similar content being viewed by others
References
Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR et al (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260:812–816
Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430–433
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214–218
Bellacosa A (2001) Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ 8:1076–1092
Benchimol S (2001) p53-dependent pathways of apoptosis. Cell Death Differ 8:1049–1051
Chiaravalli AM, Furlan D, Facco C, Tibiletti MG, Dionigi A, Casati B, Albarello L, Riva C, Capella C (2001) Immunohistochemical pattern of hMLH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences. Virchows Arch 438:39–48
Davis TW, Vilson-Van Patten C, Meyers M, Kunugi KA, Cuthill S, Reznikoff C, Garces C, Boland CR, Kinsella TJ, Fishel T, Boothman DA (1998) Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation. Cancer Res 58:767–778
Fearon ER (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science 278:1043–1050
Fei P, Bernhard EJ, El-Deiry WS (2002) Tissue-specific induction of p53 targets in vivo. Cancer Res 62:7316–7327
Fink D, Nebel S, Aebi S, Zheng H, Kim HK, Christen RD, Howell SB (1997) Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissues. Br J Cancer 76:890–893
Fink D, Aebi S, Howell SB (1998) The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1–6
Green SE, Bradburn DM, Varma JS, Burn J (1998) Hereditary nonpolyposis colorectal cancer. Int J Colorect Dis 13:3–12
Hamid AA, Mandai M, Konishi I, Nanbu K, Tsuruta Y, Kusakari T, Kariya M, Kita M, Shingo (2002) Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma. Cancer 94:997–1005
Irving JA, Dupuis B, Wang L, Gilks CB (2002) Cyclical expression of the DNA mismatch repair enzyme hMLH1 in normal endometrium. Fertil Steril 78:195–196
Leach FS, Polyak K, Burrell M, Johnson K, Hill D, Dunlop MG, Wylie AH, Peltomaki P, de la Chapelle A, Hamilton SR, Kinzler KW, Vogelstein B (1996) Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 56:235–240
Lichnovsky V, Kolar Z, Murray P, Hlobilkova A, Cernochova D, Pospisilova E, Vojtesek B, Nenutil R (1998) Differences in p53 and Bcl-2 expression in relation to cell proliferation during the development of human embryos. Mol Pathol 51:131–137
Lineham WM, Shipley WU, Longo DL (1989) Cancer of the kidney and ureter. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 3rd edn. JB Lippicott, Philadelphia, pp 979–1007
Lynch HT, Watson P, Kriegler M, Lynch JF, Lanspa SJ, Marcus J, Smyrk T, Fitzgibbons RJ, Cristofaro G (1988) Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II). Dis Colon Rectum 31:372–377
Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ, Boland CR (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer. An updated review. Gastroenterology 104:1535–1549
Mello JA, Acharya S, Fishel R, Essigmann JM (1996) The mismatch-repair protein HMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem Biol 3:579–589
Mendelsohn J (1991) Principles of neoplasia. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK (eds) Harrisons’s principles of internal medicine, 12th edn. McGraw-Hill, Inc., New York, pp 1576–1586
Meyers M, Theodosiou M, Acharya S, Odegaard E, Wilson T, Lewis JE, Davis TW, Wilson-Van patten C, Rishel R, Boothman DA (1997) Cell cycle regulation of the human DNA mismatch repair genes hMSH2, hMLH1, and hPMS2. Cancer Res 57:206–208
Meyers M, Wagner MW, Hwang HS, Kinsella TJ, Boothman DA (2001) Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res 61:5193–5201
Paraf F, Gilquin M, Longy M, Gilbert B, Gorry P, Petit B, Labrousse F (2001) MLH1 and MSH2 protein immunohistochemistry is useful for detection of hereditary non-polyposis colorectal cancer in young patients. Histopathology 39:250–258
Pratt CB, Parham DM, Rao BN, Fleming ID, Dilawari R (1988) Multiple colorectal carcinomas, polyposis coli and neurofibromatosis. J Natl Cancer Inst 80:1170–1172
Pratt CB, Jane JA (1991) Multiple colorectal carcinomas, polyposis coli and neurofibromatosis, followed by multiple glioblastoma multiforme. J Natl Cancer Inst 83:880–881
Reitmair AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, Waterhouse P, Mittrucker HW, Wakeham A, Liu B et al (1995) MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11:64–71
Ricciardome MD, Özcelik T, Cevher B, Özdag H, Tuncer M, Gürgey A, Uzunalimoglu Ö, Cetinkaya H, Tanyeli A, Erken E, Özturk M (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type I. Cancer Res 59:290–293
Scartozzi M, Bianchi F, Rosati S, Galizia E, Antolini A, Loretelli C, Piga A, Bearzi I, Cellerino R, Porfiri E (2002) Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 20:1203–1208
Thompson D, Easton DF, Breast Cancer Linkage Consortium (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358–1365
Venkitaraman AR (2002) Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171–182
Watson P, Lynch PT (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71:677–685
Watson P, Vasen HF, Mecklin JP, Jarvinen H, Lynch HT (1994) The risk of endometrial cancer in hereditary non polyposis colorectal cancer. Am J Med 96:516–520
Whiteside D, McLeod R, Graham G, Steckley JL, Booth K, Somerville MJ, Andrew SE (2002) A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple cafe-au-lait spots. Cancer Res 62:359–362
Zhang H, Richards B, Wilson T, Lloyd M, Cranston A, Thorburn A, Fishel R, Meuth M (1999) Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res 59:3021–3027
Acknowledgements
This work was supported by Ministry of Health Care of the Czech Republic, grant no. NC/6741–3. I am indebted to reviewers for their helpful comments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Plevová, P., Sedláková, E., Zapletalová, J. et al. Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer. Virchows Arch 446, 112–119 (2005). https://doi.org/10.1007/s00428-004-1139-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-004-1139-5